Nona Biosciences and Pfizer Announce Strategic Research Collaboration to Accelerate Antibody Discovery
- Written by PR Newswire
![]() |
Agreement includes license to Nona's fully human HCAb platform for preclinical antibody discovery
CAMBRIDGE, Mass., Nov. 19, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I® (Idea to IND), today announced a non-exclusive license...














